GlassScriptPhysician profile
Keith Poindexter
NPI 1427060201
$3,835.28
in general payments reported to CMS, 2019-2025
20 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $346 · 2021: $339 · 2022: $1,354 · 2023: $557 · 2024: $266 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,874.96 | 2019-2024 | Myday Contact Lens |
| Alcon Vision LLC | $664.24 | 2019-2025 | Clareon, Dailies Total1, Precision 1 |
| Sun Pharmaceutical Industries INC. | $245.53 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $214.20 | 2022-2025 | Infuse, Vyzulta, Biotrue |
| Biotissue Holdings INC. | $137.36 | 2020-2022 | |
| Notal Vision, INC. | $121.30 | 2024-2025 | Foresee Home |
| Shire North American Group INC | $82.88 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $77.93 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $63.75 | 2019-2021 | |
| Allergan, INC. | $56.43 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $53.35 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $36.30 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $34.66 | 2021 | |
| Horizon Therapeutics Plc | $33.86 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.43 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $27.90 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $26.63 | 2023 | Tyrvaya |
| Thea Pharma INC. | $22.07 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Maculogix, INC. | $9.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Poindexter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.